Major pitfalls of protein kinase inhibitors prescription: A review of their clinical pharmacology for daily use-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Major pitfalls of protein kinase inhibitors prescription: A review of their clinical pharmacology for daily use

Published:2019-09 Issue: Volume:141 Page:112-124
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Gougis Paul^ORCID,Palmieri Lola-Jade,Funck-Brentano Christian^ORCID,Paci Angelo,Flippot Ronan,Mir Olivier,Coriat Romain

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference149 articles.

1. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma;Abou-Alfa;J. Clin. Oncol.,2006

2. Effect of black seed on dextromethorphan O- and N-demethylation in human liver microsomes and healthy human subjects;Al-Jenoobi;Drug Metab. Lett.,2010

3. Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma;Antoun;Ann. Oncol.,2010

4. Sorafenib exposure decreases over time in patients with hepatocellular carcinoma;Arrondeau;Invest. New Drugs,2012

5. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice;Bailey;Clin. Pharmacol. Ther.,2003

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine kinase inhibitors in cancers: Treatment optimization – Part II;Critical Reviews in Oncology/Hematology;2024-08

2. Reply to: “Therapeutic Drug Monitoring of Oral Oncology Drugs: Another Example of Maslow's Hammer” and “Therapeutic Drug Monitoring of Oral Oncology Drugs: Finding the Right Nails”;Clinical Pharmacology & Therapeutics;2024-07-05

3. A Score to Predict the Clinical Usefulness of Therapeutic Drug Monitoring: Application to Oral Molecular Targeted Therapies in Cancer;Clinical Pharmacology & Therapeutics;2024-02-23

4. Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method;Therapeutic Drug Monitoring;2024-02-06

5. Management of cancer treatments in hemodialysis patients;Bulletin du Cancer;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3